持续皮下胰岛素输注在糖尿病患者围手术期应用价值的评估
http://www.100md.com
《第四军医大学学报》
胰岛素;注射,皮下;手术期间,,胰岛素;注射,皮下;手术期间,0引言,1对象和方法,2结果,3讨论,【参考文献】
Value of continuous subcutaneous insulin infusion during perioperation of diaketic patientsCHEN Fei, ZHANG NanYan, ZHAO KuiYan, WANG Li, SUN HuiHui, GAO Bin, JI QiuHe
Department of Endocrinology, Xijing Hospital, Fourth Military Medical University, Xian 710033, China
【Abstract】 AIM: To assess the effect of continuous subcutaneous insulin infusion (CSII) during perioperation in diabetic patients. METHODS: Eightyseven diabetic patients in perioperation who need insulin therapy were randomly divided into CSII group (n=46, 2 T1DM and 44 T2DM) and multiple subcutaneous insulin infusion (MSII) group (n=41, 3 T1DM and 38 T2DM). The target of blood glucose control was 3.9-7.9 mmol/L. The time of blood glucose for achieving the target, and preoperative preparation time, length of stay, success rate of preoperative blood glucose control, glucose level at 3 rd day of insulin treatment, expense for preoperative glucose control and total expense of hospitalization were compared between the 2 groups. RESULTS: The time of blood glucose for achieving the target in CSII group[(2.2±1.6)d]was shorter than that in MSII group[(8.5±4.8) d, P<0.01];the time of preoperative preparation in CSII group [(4.6±3.2) d] was shorter than that in MSII group [(11.8±6.8) d, P<0.01]; the length of stay in CSII group[(19.6±9.4) d]was also shorter than that in MSII [(26.2±10.0) d, P<0.01];the success rate of preoperative blood glucose control in CSII group was 85.4%, higher than that in MSII (53.2%, P<0.01). Fasting glucose level at 3 rd day of insulin treatment in CSII group [(7.5±1.8) mmol/L] was lower than that in MSII [(10.5±2.6) mmol/L, P<0.01]. All of above results proved that CSII could help to obtain better glucose control. Although expense for preoperative glucose control in CSII group [(867.9±574.4) RMB] was higher than that in MSII [(497.9±283.6) RMB, P<0.01], total expense of hospitalization in CSII group [(25007±18048) RMB] was almost as much as that in MSII [(24919±21617)RMB, P>0.05). CONCLUSION: The application of CSII in preoperation of diabetic patients can bring better glucose control and shorten hospitalization time, therefore the total expense of hospitalization is not increased. ......
您现在查看是摘要页,全文长 9201 字符。